Again, at BioCanRx we are very focused on key deliverables: the number of clinical trials taking place in Canada and the number of patients treated. We communicate these results to our SSF secretariat, which then assembles all of the results from similar SSF recipients.
When we're thinking about different sectoral strategies, there's really a need to develop goalposts for where Canada wants to be and where we want to go. I think we took a first stab at this with a biomanufacturing and life sciences strategy—
